SNY.TO Sanofi CDR (CAD Hedged)

Healthcare Drug Manufacturers - General Toronto Exchange
- CAD
Market cap
-
P/E
24.0x
P/B
0.23x
ROE
9.1%
Dividend yield
4.03%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is SNY.TO undervalued?

Graham number

The Graham number of Sanofi CDR (CAD Hedged) cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sanofi CDR (CAD Hedged) fundamental analysis

No fundamental analysis for Sanofi CDR (CAD Hedged) yet.

Sanofi CDR (CAD Hedged) stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sanofi CDR (CAD Hedged)

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, boo…

Full company profile